Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Cabaletta Bio Inc (NASDAQ: CABA) was $2.55 for the day, up 2.82% from the previous closing price of $2.48. In other words, the price has increased by $2.82 from its previous closing price. On the day, 4.29 million shares were traded. CABA stock price reached its highest trading level at $2.555 during the session, while it also had its lowest trading level at $2.3.
Ratios:
Our analysis of CABA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.78. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Evercore ISI Downgraded its rating to In-line which previously was Outperform and also lowered its target price recommendation from $15 to $6.
Wells Fargo Downgraded its Overweight to Equal Weight on December 19, 2024, whereas the target price for the stock was revised from $12 to $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 233236336 and an Enterprise Value of 63447344.
Stock Price History:
The Beta on a monthly basis for CABA is 3.21, which has changed by -0.42825115 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $5.46, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is 8.81%, while the 200-Day Moving Average is calculated to be 36.24%.
Shares Statistics:
CABA traded an average of 3.68M shares per day over the past three months and 7452630 shares per day over the past ten days. A total of 91.45M shares are outstanding, with a floating share count of 79.01M. Insiders hold about 13.61% of the company’s shares, while institutions hold 75.51% stake in the company. Shares short for CABA as of 1760486400 were 11219561 with a Short Ratio of 3.05, compared to 1757894400 on 5567200. Therefore, it implies a Short% of Shares Outstanding of 11219561 and a Short% of Float of 12.479999999999999.
Earnings Estimates
The performance of Cabaletta Bio Inc (CABA) in the stock market is under the watchful eye of 5.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.38 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.46 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$1.64, with 5.0 analysts recommending between -$1.04 and -$2.2.
